Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT05737342
NA

Effect of ANKASCIN 568-P Products on Decreasing HbA1c and Regulating Blood Glucose

Sponsor: SunWay Biotech Co., LTD.

View on ClinicalTrials.gov

Summary

This study is a randomized, double-blind, placebo-controlled, parallel-controlled trial (24 weeks in total), divided into three periods (screening, treatment, and discontinuation follow-up)

Official title: Effect of ANKASCIN 568-P Products on Decreasing HbA1c and Regulating Blood Glucose- A Double-blind, Placebo-controlled Clinical Research

Key Details

Gender

All

Age Range

20 Years - Any

Study Type

INTERVENTIONAL

Enrollment

80

Start Date

2023-04-01

Completion Date

2025-10-31

Last Updated

2025-08-28

Healthy Volunteers

No

Interventions

DIETARY_SUPPLEMENT

ANKASCIN 568-P Red yeast rice capsules

Product ingredients: ANKASCIN 568-P red yeast rice product 440 mg,microcrystalline ,cellulose,Maltodextrin; capsule shell composition: HPMC (hydroxypropyl methylcellulose), purified water, titanium dioxide, gellan gum.

DIETARY_SUPPLEMENT

Placebo Capsules

Maltodextrin was used as a placebo

Locations (1)

Tri-Service General Hospital, National Defense Medical Center, Taipei city,

Taipei, Taiwan